health.oliverwyman.com Open in urlscan Pro
54.75.119.226  Public Scan

Form analysis
1 forms found in the DOM

GET /search.html

<form action="/search.html" method="get">
  <input type="search" name="q" placeholder="Search">
  <input type="submit" value="Search">
</form>

Text Content

Facebook Twitter LinkedIn Instagram Email Printer Google Plus

 * Transform Care
 * Engage Consumers
 * Drive Innovation
 * Maximize Value
 * 


 * Transform Care
 * Engage Consumers
 * Drive Innovation
 * Maximize Value

Drive Innovation January 27, 2022


UNDERSTANDING THE VALUE EQUATION


A LOOK AT WHAT'S INSIDE OLIVER WYMAN'S HEALTH INNOVATION JOURNAL VOL. 5

Oliver Wyman Health

 @OWHealthEditor  Email


Conversations around healthcare’s switch to value-based models often center on
reimbursement. Are payments being redesigned to incentivize new care models? Are
they replicable? When can we leave fee for service behind?

The other critical part of that equation is: are these experiments delivering
value for patients, clinicians, and the healthcare system overall? To be sure,
cost, payment, and care are inextricably linked. But understanding how
technology, consumerism, clinician well-being, aging, and a host of other
factors are being addressed is essential to moving the industry forward.

Oliver Wyman’s Health Innovation Journal Volume 5 analyzes a number of the
biggest trends impacting the industry’s transformation, from creating digital
doctors and understand the impact of price transparency to evolving consumer
behaviors in a digital age and addressing systemic racism. Through a mix of
articles, videos, and podcasts, this year’s Journal, which is fully digital for
the first time, offers insights from Oliver Wyman partners who are the
front-lines helping organizations develop new business strategies, as well as
from some of the industry’s most innovative leaders.


HIGHLIGHTS FROM THIS YEAR’S HEALTH INNOVATION JOURNAL

Five Ways to Reshape Healthcare: Oliver Wyman’s Ashley Smith details areas where
the value proposition is being redefined in healthcare: care in the home,
behavioral health, the electronic medical record, pharmaceuticals, and
population health. In a video presentation, Smith shares ideas for how the
industry can bring science and business together in unique ways. As she points
out, we are past the time when big players and current incumbents are the
default winners and incremental change is the norm.

> "We are past the time when big players and current incumbents are the default
> winners and incremental change is the norm."
> 
> Ashley Smith Partner, Health and Life Sciences, Oliver Wyman

Digital Doctors: There’s an enormous upside to getting clinicians to embrace
technology more fully, but we can’t lose sight of the fourth element of the
Quadruple Aim — bringing joy back to practicing medicine. In this article, we
look at how organizations can adopt technology in a meaningful way to benefit
patients and clinicians.

Value or Vaporware: Mergers, acquisitions, partnerships, and investments are
creating a host of unique combinations. That M&A and partnership activity is
being backed by an explosion in capital flowing into the industry. Increasingly,
those investments are being directed toward value-based models. We take a closer
look at areas for investors to consider as they think about backing different
models of care and payment, or a new technology.

Aging Sustainably: By 2050, more than 20% of the world’s population will be 60
years of age or older. Programs are in place across the globe to not only
improve health, but the quality of life for this demographic. We identified six
areas where stakeholders can come together to reimagine how services are
delivered and healthy aging becomes a strategic priority.

Understanding the Engaged Consumer: The COVID-19 pandemic reshaped how consumers
access healthcare services. Findings from our latest Consumer Healthcare Survey
offer insights into how healthcare companies need to realign their strategies to
meet evolving consumer expectations.

Dig deeper into this year's Oliver Wyman Health Innovation Journal here.

 * Topic
 * Future Market
 * OWHIC

Insights in your inbox

Subscribe
January 27, 2022
Betting on Innovation and Overcoming Resistance...

April 09, 2021
Fyodor Urnov on What's Next For Gene Therapy

October 27, 2020
2030 Projections for Inpatient Bed Supply


FOLLOW US @OWHEALTHEDITOR

 * Is the future of care truly digital? Learn more from our recent Consumer
   Healthcare Survey via @Forbes #OWHealth https://t.co/e1d9d5E0No

 * Health plans all over the country are looking for ways to serve their member
   populations better, reduce the cost of care for their communities, and
   diversify revenues. More from our chat with Ricardo Johnson @carefirst >
   https://t.co/V8TP72zUFg #OWHealth #healthcareinnovation

 * Executives have detailed plans to take on more risk and build on advances in
   life sciences, and are optimistic about #Medicare Advantage despite missed
   enrollment targets. More reflections from the @jpmorgan Healthcare Conference
   > https://t.co/pvQSBQRmRV #OWHealth https://t.co/7rs4rAPPOe

 * Examining key trends impacting the industry — how investors view the shift to
   value-based care, creating the digital clinician, building systems that
   support an aging population, and more > https://t.co/hw73UbaXZA #OWHealth
   https://t.co/JrVGCLDtvw

 * RT @annsomerswh: Health care #predictions season is a favorite. While I love
   reading all the visions for what's to come, this may be my fav…

 * RT @OliverWyman: How can #healthcare organizations push innovations at an
   accelerated pace? Five ways to reshape healthcare in the Health I…

 * 2022 Predictions: @OliverWyman's @SamOnHealth shares his outlook on #COVID19,
   #MentalHealth, #HealthIT, and more > https://t.co/4Lxhgr0poH #OWHealth

 * RT @statnews: “It’s been incredible ... We’ve seen patients who had multiple
   lines of therapies and progressed after all of those, [then] g…

 * Similar to every sector in #healthcare, pharmaceutical companies are
   undergoing significant changes to their business and operating models. Learn
   more about three key considerations for the industry here >
   https://t.co/Ve0IUJWlbz #OWHealth #JPM2022 https://t.co/kNuTnvLfTy

 * RT @OliverWyman: 2022 Pharma Predictions: Pharmaceutical giants are shedding
   business units, choosing to focus on innovative pharma operati…

 * Is the future of care truly digital? Learn more from our recent Consumer
   Healthcare Survey via @Forbes #OWHealth https://t.co/e1d9d5E0No

 * Health plans all over the country are looking for ways to serve their member
   populations better, reduce the cost of care for their communities, and
   diversify revenues. More from our chat with Ricardo Johnson @carefirst >
   https://t.co/V8TP72zUFg #OWHealth #healthcareinnovation

PrevNext

Marsh McLennan is the leader in risk, strategy and people, helping clients
navigate a dynamic environment through four global businesses.

 * 
 * 
 * 
 * 

 * Share
 * 
 * 

 * Terms Of Use
 * Privacy Notice
 * Cookie Notice
 * Manage Cookies

 * 

This website uses cookies We and our partners may process your data through the
use of cookies (and other tracking technologies). Some cookies are necessary to
make our website work, so they can’t be turned off. Others are not strictly
necessary but are useful to optimize the performance of this site, help us
assess site usage, and give you the best user experience. You can consent to the
use of such cookies by clicking "Accept", you can reject our use of such cookies
by clicking "Reject", or you can make individualized decisions by clicking
"Manage Cookies". To learn more about cookies, read our Cookie Notice.
Accept Manage Cookies Reject